Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Titan Machinery Inc. TITN |
Nantahala Capital Management, LLC | 1,625,276 7.027% |
1,625,276![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
Nantahala Capital Management, LLC | 1,038,371 9.654% |
1,038,371![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management, LLC | 10,159,349 9.990% |
6,683,636![]() (+192.30%) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | uniQure N.V. QURE |
Nantahala Capital Management, LLC | 2,982,013 6.123% |
-176,014![]() (-5.57%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,052,204 9.990% |
4,052,204![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
Nantahala Capital Management, LLC | 2,834,336 9.990% |
36,748![]() (+1.31%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Xtant Medical Holdings, Inc. XTNT |
Nantahala Capital Management, LLC | 11,394,000 8.214% |
11,394,000![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA |
Nantahala Capital Management, LLC | 2,924,021 5.557% |
470,616![]() (+19.18%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Viemed Healthcare, Inc. VMD |
Nantahala Capital Management, LLC | 1,135,122 2.924% |
1,135,122![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | Bioventus Inc. BVS |
Nantahala Capital Management, LLC | 4,350,870 6.686% |
-1,626,601![]() (-27.21%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | BlackSky Technology Inc. BKSY |
Nantahala Capital Management, LLC | 2,450,000 8.562% |
2,450,000![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management, LLC | 3,677,739 9.990% |
447,836![]() (+13.87%) |
Filing History |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | eHealth, Inc. EHTH |
Nantahala Capital Management, LLC | 1,911,821 6.502% |
1,911,821![]() (New Position) |
Filing History |
2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | Codexis, Inc. CDXS |
Nantahala Capital Management, LLC | 2,967,808 4.263% |
-1,625,095![]() (-35.38%) |
Filing History |
2024-11-13 5:30 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
Nantahala Capital Management, LLC | 1,794,141 9.990% |
1,794,141![]() (New Position) |
Filing History |
2024-11-06 4:31 pm Purchase |
2024-11-06 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 254,632 15.990% |
169,946![]() (+200.68%) |
Filing History |
2024-11-05 4:32 pm Purchase |
2024-10-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management, LLC | 3,945,209 30.400% |
1,983,139![]() (+101.07%) |
Filing History |
2024-10-01 4:53 pm Unchanged |
2024-09-27 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 84,686 10.000% |
0 (Unchanged) |
Filing History |
2024-09-24 4:31 pm Purchase |
2024-09-19 | 13D | America's Car-Mart, Inc. CRMT |
Nantahala Capital Management, LLC | 544,686 6.700% |
544,686![]() (New Position) |
Filing History |
2024-09-20 7:28 pm Purchase |
2024-09-20 | 13D | Evoke Pharma, Inc. EVOK |
Nantahala Capital Management, LLC | 84,686 10.000% |
84,686![]() (New Position) |
Filing History |